Literature DB >> 32166672

Different Re-centrifugation Conditions for Infectious Disease Screening Using the Abbott I2000.

Dong-Jiang Xu1, Ke-di Wang2, Jun Wu3.   

Abstract

We investigated whether an ordinary centrifuge can achieve the standard centrifugal effect required according to specifications for infectious disease screening using the Abbott i2000. Samples were collected and centrifuged following a standard operating procedure (SOP). They were then divided into three groups according to the results of the initial screening tests: a negative group, weak-positive group, and positive group. Twenty negative samples and all weak-positive and positive samples were re-analyzed. Two tubes for each re-analyzed sample were centrifuged simultaneously, one for 10 min at 10 000 × g, per recommendations, and one for 10 min at 2750 × g. No significant difference was found between the groups using different centrifugal forces. There was a strong correlation in the quantitative values between the two conditions of centrifugation. Consistency analysis showed a Cronbach's alpha > 0.8 for detection of Treponema pallidum, human immunodeficiency virus (HIV), hepatitis C virus (HCV), and hepatitis B surface antigen in the three groups (negative group, weak-positive group, and positive group) under different centrifugation conditions. Strong consistency was found under different centrifugal conditions, regardless of the initial testing results. In conclusion, we conducted centrifugation steps in duplicate, according to infectious disease screening protocols. Our study showed that all samples should be centrifuged using a recommended relative centrifugal force after a proper clotting time, as in the standard operating procedure of our laboratory. In this way, we were able to obtain the same results using an ordinary centrifuge as those obtained using a high-speed centrifuge, such as the Abbott i2000.

Entities:  

Keywords:  high-speed centrifuge; infectious disease screening; ordinary centrifuge

Mesh:

Substances:

Year:  2020        PMID: 32166672     DOI: 10.1007/s11596-020-2153-9

Source DB:  PubMed          Journal:  Curr Med Sci        ISSN: 2523-899X


  8 in total

1.  Preanalytical quality improvement. In pursuit of harmony, on behalf of European Federation for Clinical Chemistry and Laboratory Medicine (EFLM) Working group for Preanalytical Phase (WG-PRE).

Authors:  Giuseppe Lippi; Giuseppe Banfi; Stephen Church; Michael Cornes; Gabriella De Carli; Kjell Grankvist; Gunn B Kristensen; Mercedes Ibarz; Mauro Panteghini; Mario Plebani; Mads Nybo; Stuart Smellie; Martina Zaninotto; Ana-Maria Simundic
Journal:  Clin Chem Lab Med       Date:  2015-02       Impact factor: 3.694

2.  Evaluation of the performance of the Abbott ARCHITECT HIV Ag/Ab Combo Assay.

Authors:  Pollyanna Chavez; Laura Wesolowski; Pragna Patel; Kevin Delaney; S Michele Owen
Journal:  J Clin Virol       Date:  2011-10-07       Impact factor: 3.168

3.  The Performance of the Abbott i2000 for Measuring Serum Markers of Infectious Diseases.

Authors:  Linchuan Wang; Wei Chen; Yan Yu
Journal:  J Clin Lab Anal       Date:  2016-06-15       Impact factor: 2.352

4.  False-positive troponin I measured with the Abbott AxSYM attributed to fibrin interference.

Authors:  Steven C Kazmierczak; Harmanjatinder Sekhon; Christopher Richards
Journal:  Int J Cardiol       Date:  2005-05-11       Impact factor: 4.164

5.  A signal-to-cutoff ratio in the Abbott architect HIV Ag/Ab Combo assay that predicts subsequent confirmation of HIV-1 infection in a low-prevalence setting.

Authors:  Tomas Ostergaard Jensen; Peter Robertson; Ross Whybin; Ian Chambers; Monica Lahra; William Rawlinson; Jeffrey John Post
Journal:  J Clin Microbiol       Date:  2015-02-11       Impact factor: 5.948

6.  The significance of repeat testing in Turkish blood donors screened with HBV, HCV and HIV immunoassays and the importance of S/CO ratios in the interpretation of HCV/HIV screening test results and as a determinant for further confirmatory testing.

Authors:  Ali Acar; Sabri Kemahli; Husnu Altunay; Erdogan Kosan; Oral Oncul; Levent Gorenek; Saban Cavuslu
Journal:  Transfus Med       Date:  2010-01-05       Impact factor: 2.019

Review 7.  Preanalytical Processing and Biobanking Procedures of Biological Samples for Metabolomics Research: A White Paper, Community Perspective (for "Precision Medicine and Pharmacometabolomics Task Group"-The Metabolomics Society Initiative).

Authors:  Jennifer A Kirwan; Lorraine Brennan; David Broadhurst; Oliver Fiehn; Marta Cascante; Warwick B Dunn; Michael A Schmidt; Vidya Velagapudi
Journal:  Clin Chem       Date:  2018-06-19       Impact factor: 8.327

8.  Identifying Risk Factors for Recent HIV Infection in Kenya Using a Recent Infection Testing Algorithm: Results from a Nationally Representative Population-Based Survey.

Authors:  Andrea A Kim; Bharat S Parekh; Mamo Umuro; Tura Galgalo; Rebecca Bunnell; Ernest Makokha; Trudy Dobbs; Patrick Murithi; Nicholas Muraguri; Kevin M De Cock; Jonathan Mermin
Journal:  PLoS One       Date:  2016-05-19       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.